Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000232134 | SCV000288572 | benign | Wilms tumor 1 | 2024-11-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001545830 | SCV001765237 | likely benign | not provided | 2019-03-25 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001545830 | SCV002009828 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001545830 | SCV001930702 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001545830 | SCV001966598 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003967643 | SCV004782289 | likely benign | GPC3-related disorder | 2022-04-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |